Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
X
XBI
State Street SPDR S&P Biotech ETF
136.2
0
USD
+9917.65%
Sector:
Financial
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+9917.65%
Monthly Change
+5.17%
6 month change
+11.88%
Year Change
+23.67%
Previous Close
1.3
6
Open
136.4
8
Low
136.1
5
High
136.7
3
Volume
649
Markets
US ETFs
XBI
Open full chart
Full chart
Overview
All holdings
Heatmap
Top holdings
Market Value
Shares
Weight %
ABBV
AbbVie Inc
98.3 M
430.4 K
1.3%
GILD
Gilead Sciences Inc
98.0 M
798.7 K
1.2%
Avidity Biosciences Inc
98.0 M
1.4 M
1.2%
IONS
Ionis Pharmaceuticals Inc
97.5 M
1.2 M
1.2%
Cidara Therapeutics Inc
97.5 M
441.3 K
1.2%
UTHR
United Therapeutics Corp
97.4 M
199.9 K
1.2%
Exact Sciences Corp
97.2 M
957.0 K
1.2%
BIIB
Biogen Inc
96.0 M
545.8 K
1.2%
MIRM
Mirum Pharmaceuticals Inc
96.0 M
1.2 M
1.2%
ALNY
Alnylam Pharmaceuticals Inc
95.3 M
239.6 K
1.2%
NTRA
Natera Inc
95.2 M
415.7 K
1.2%
CELC
Celcuity Inc
94.9 M
951.6 K
1.2%
SRRK
Scholar Rock Holding Corp
94.8 M
2.2 M
1.2%
ALKS
Alkermes PLC
94.7 M
3.4 M
1.2%
TGTX
TG Therapeutics Inc
94.4 M
3.2 M
1.2%
ARWR
Arrowhead Pharmaceuticals Inc
93.4 M
1.4 M
1.2%
PTGX
Protagonist Therapeutics Inc
92.6 M
1.1 M
1.2%
VKTX
Viking Therapeutics Inc
90.8 M
2.6 M
1.2%
INSM
Insmed Inc
88.8 M
510.4 K
1.1%
ADMA
ADMA Biologics Inc
88.5 M
4.9 M
1.1%
1
2
3
4
5
6
7
8
News
First Quarter Earnings: Sharpening Sector Divergence
Is State Street SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now?
3 Reasons To Stick With Growth Stocks In Rotating Markets
Seeking Innovation Beyond Tech? Insight On Healthcare Stocks
Biotech Investors Are Tuning Out the MAHA Chaos
Makary's Successor Faces Tough Task Managing FDA Amid Budget Cuts
Maravai LifeSciences: Better Earnings Drive Gains That Ought To Be Sustainable (MRVI)
FDA Commissioner Marty Makary Expected To Resign, Ending Turbulent Stint
Why I Now Favor A Barbell Model Over Ray Dalio’s All-Weather Portfolio (SPY)
What's The Dominant Trend In Earnings: AI Or Geopolitics?
Why This Biotech ETF — The IBD Stock Of The Day — Just Reentered Its Buy Zone
Broadcom, Google And Caterpillar Lead AI Charge On Must-See List